PD-L1 Test Debated in Gastroesophageal Cancer Immunotherapy PD-L1 Test Debated in Gastroesophageal Cancer Immunotherapy

Clinicians are wondering whether measuring programmed death –ligand 1 (PD-L1) is essential before prescribing checkpoint inhibitors for gastroesophageal cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news